000 01618 a2200469 4500
005 20250515150920.0
264 0 _c20090128
008 200901s 0 0 eng d
022 _a1464-3405
024 7 _a10.1016/j.bmcl.2008.11.037
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aMiller, Lori M
245 0 0 _aLead identification to generate 3-cyanoquinoline inhibitors of insulin-like growth factor receptor (IGF-1R) for potential use in cancer treatment.
_h[electronic resource]
260 _bBioorganic & medicinal chemistry letters
_cJan 2009
300 _a62-6 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAntineoplastic Agents
_xchemical synthesis
650 0 4 _aHumans
650 0 4 _aNitriles
_xchemical synthesis
650 0 4 _aQuinolines
_xchemical synthesis
650 0 4 _aReceptor, IGF Type 1
_xantagonists & inhibitors
650 0 4 _aStructure-Activity Relationship
700 1 _aMayer, Scott C
700 1 _aBerger, Dan M
700 1 _aBoschelli, Diane H
700 1 _aBoschelli, Frank
700 1 _aDi, Li
700 1 _aDu, Xuemei
700 1 _aDutia, Minu
700 1 _aFloyd, Middleton B
700 1 _aJohnson, Mark
700 1 _aKenny, Cynthia Hess
700 1 _aKrishnamurthy, Girija
700 1 _aMoy, Franklin
700 1 _aPetusky, Susan
700 1 _aTkach, Diane
700 1 _aTorres, Nancy
700 1 _aWu, Biqi
700 1 _aXu, Weixin
773 0 _tBioorganic & medicinal chemistry letters
_gvol. 19
_gno. 1
_gp. 62-6
856 4 0 _uhttps://doi.org/10.1016/j.bmcl.2008.11.037
_zAvailable from publisher's website
999 _c18496619
_d18496619